JPS5936696A - ２′―デオキシ―５―置換ウリジン誘導体及びそれを含有する抗腫瘍剤 - Google Patents

２′―デオキシ―５―置換ウリジン誘導体及びそれを含有する抗腫瘍剤

Info

Publication number
JPS5936696A
JPS5936696A JP14515182A JP14515182A JPS5936696A JP S5936696 A JPS5936696 A JP S5936696A JP 14515182 A JP14515182 A JP 14515182A JP 14515182 A JP14515182 A JP 14515182A JP S5936696 A JPS5936696 A JP S5936696A
Authority
JP
Japan
Prior art keywords
group
ring
general formula
compound
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14515182A
Other languages
English (en)
Japanese (ja)
Other versions
JPS644520B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Setsuo Fujii
藤井　節郎
Junichi Yamashita
純一 山下
Setsuo Takeda
武田　節夫
Sanji Yasumoto
三治 安本
Norio Saimi
采見　憲男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP14515182A priority Critical patent/JPS5936696A/ja
Publication of JPS5936696A publication Critical patent/JPS5936696A/ja
Publication of JPS644520B2 publication Critical patent/JPS644520B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP14515182A 1982-08-20 1982-08-20 ２′―デオキシ―５―置換ウリジン誘導体及びそれを含有する抗腫瘍剤 Granted JPS5936696A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14515182A JPS5936696A (ja) 1982-08-20 1982-08-20 ２′―デオキシ―５―置換ウリジン誘導体及びそれを含有する抗腫瘍剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14515182A JPS5936696A (ja) 1982-08-20 1982-08-20 ２′―デオキシ―５―置換ウリジン誘導体及びそれを含有する抗腫瘍剤

Publications (2)

Publication Number Publication Date
JPS5936696A true JPS5936696A (ja) 1984-02-28
JPS644520B2 JPS644520B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-01-25

Family

ID=15378596

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14515182A Granted JPS5936696A (ja) 1982-08-20 1982-08-20 ２′―デオキシ―５―置換ウリジン誘導体及びそれを含有する抗腫瘍剤

Country Status (1)

Country Link
JP (1) JPS5936696A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919437B1 (en) 1998-06-11 2005-07-19 Isis Pharmaceuticals, Inc. Synthetic methods and intermediates for triester oligonucleotides
JP2022515944A (ja) * 2018-12-26 2022-02-24 イルミナ ケンブリッジ リミテッド ３’－ヒドロキシブロッキング基を有するヌクレオシドおよびヌクレオチド、ならびにそれらのポリヌクレオチドシーケンシング方法における使用
JP2023531009A (ja) * 2020-06-22 2023-07-20 イルミナ ケンブリッジ リミテッド ３’アセタールブロッキング基を有するヌクレオシド及びヌクレオチド

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102410575B (zh) * 2011-10-18 2014-06-25 李华玉 吸收式分级供热系统

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919437B1 (en) 1998-06-11 2005-07-19 Isis Pharmaceuticals, Inc. Synthetic methods and intermediates for triester oligonucleotides
JP2022515944A (ja) * 2018-12-26 2022-02-24 イルミナ ケンブリッジ リミテッド ３’－ヒドロキシブロッキング基を有するヌクレオシドおよびヌクレオチド、ならびにそれらのポリヌクレオチドシーケンシング方法における使用
US11293061B2 (en) * 2018-12-26 2022-04-05 Illumina Cambridge Limited Sequencing methods using nucleotides with 3′ AOM blocking group
US11827931B2 (en) 2018-12-26 2023-11-28 Illumina Cambridge Limited Methods of preparing growing polynucleotides using nucleotides with 3′ AOM blocking group
US12227802B2 (en) 2018-12-26 2025-02-18 Illumina Cambridge Limited Nucleotides with a 3′ AOM blocking group
JP2023531009A (ja) * 2020-06-22 2023-07-20 イルミナ ケンブリッジ リミテッド ３’アセタールブロッキング基を有するヌクレオシド及びヌクレオチド
US11787831B2 (en) 2020-06-22 2023-10-17 Illumina Cambridge Limited Nucleosides and nucleotides with 3′ acetal blocking group
US12286453B2 (en) 2020-06-22 2025-04-29 Illumina Cambridge Limited Methods of sequencing using nucleotides with 3′ acetal blocking group

Also Published As

Publication number Publication date
JPS644520B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-01-25

Similar Documents

Publication Publication Date Title
JPS6157584A (ja) 抗ウイルス化合物
CA2403264A1 (en) Chiral fluoroquinolizinone arginine salt forms
JPS5936696A (ja) ２′―デオキシ―５―置換ウリジン誘導体及びそれを含有する抗腫瘍剤
EP0074411B1 (en) Ascorbic acid derivatives
JP4000397B2 (ja) モルヒネ−６−グルクロニドの新しい結晶形熊
JPS6056996A (ja) ２′―デオキシ―５―トリフルオロメチルウリジン誘導体及びそれを含有する抗腫瘍剤
JPS62919B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE3709699C2 (de) 5-Fluoruracil-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US4371535A (en) Method of and composition for delivering 5-fluorouracil to tumors
JPH0340038B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0340036B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0363224A (ja) プロトカテキュアルデヒド類の糖誘導体
JP3068175B2 (ja) イソチアゾロ〔５，４―ｂ〕ピリジン誘導体
JPH02292213A (ja) 制癌剤
CA1102700A (en) Anticancer agent
KR860001867B1 (ko) 2'-데옥시-5-치환 우리딘 유도체의 제조방법
JPS58152898A (ja) ２′−デオキシ−５−トリフルオロメチルウリジン誘導体、その製法およびそれを含む抗腫瘍剤
JP2737240B2 (ja) 新規白金錯体および腫瘍治療剤組成物
JPH027596B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2860385B2 (ja) ビスべンジルイソキノリン誘導体
CN119790056A (zh) 三并环类衍生物、药物组合物以及应用
JPS6312477B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5872577A (ja) ２，５−アンヒドロ−ｄ−マンニト−ルおよびそのエステル類
JP3784868B2 (ja) 医薬用水和物
JPS59164330A (ja) ポリシルセスキオキサン